Published in J Clin Microbiol on January 01, 2004
Evaluation of the GenoType Mycobacterium Assay for identification of mycobacterial species from cultures. J Clin Microbiol (2006) 1.88
Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria. Biomed Res Int (2014) 1.47
Short communication: subtyping of Mycobacterium kansasii by PCR-restriction enzyme analysis of the hsp65 gene. Biomed Res Int (2013) 0.90
Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii. Antimicrob Agents Chemother (2004) 0.85
Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria. Clin Microbiol Rev (2016) 0.84
Combined rpoB duplex PCR and hsp65 PCR restriction fragment length polymorphism with capillary electrophoresis as an effective algorithm for identification of mycobacterial species from clinical isolates. BMC Microbiol (2012) 0.76
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05
Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol (1993) 18.91
PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol (1995) 4.27
DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol (1993) 3.65
Genotypic characterization of five subspecies of Mycobacterium kansasii. J Clin Microbiol (1997) 2.67
Identification of a genetically distinct subspecies of Mycobacterium kansasii. J Clin Microbiol (1992) 2.66
Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool. J Clin Microbiol (1993) 2.25
Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J Clin Microbiol (1997) 2.24
Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med (1998) 1.96
A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. Chest (1979) 1.73
Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med (1998) 1.71
Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis (1990) 1.50
Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey. J Clin Microbiol (2003) 1.33
High-catalase strains of Mycobacterium kansasii isolated from water in Texas. J Clin Microbiol (1980) 1.25
Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. Int J Tuberc Lung Dis (1999) 1.01
Large-restriction-fragment analysis of Mycobacterium kansasii genomic DNA and its application in molecular typing. J Clin Microbiol (1997) 0.99
Mycobacterium kansasii infections in patients positive for human immunodeficiency virus. Rev Infect Dis (1992) 0.97
Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis (2000) 0.91
Rifampin-resistant Mycobacterium kansasii. Clin Infect Dis (1994) 0.86
Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis (1999) 0.86
Mycobacterium kansasii and human immunodeficiency virus co-infection in London. J Infect (1998) 0.85
Mycobacterium kansasii infection in a Paris suburb: comparison of disease presentation and outcome according to human immunodeficiency virus status. Groupe dEtude Des Mycobactéries de la Seine-Saint-Denis. Int J Tuberc Lung Dis (1999) 0.83
Evaluation of a modified single-enzyme amplified-fragment length polymorphism technique for fingerprinting and differentiating of Mycobacterium kansasii type I isolates. J Clin Microbiol (2003) 0.81
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med (2007) 33.18
Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol (2006) 11.86
Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev (2006) 7.85
Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev (2002) 7.15
Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med (2002) 4.75
Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg Infect Dis (2002) 4.22
Snapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international study. J Clin Microbiol (2003) 4.19
A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother (2009) 2.92
Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J Clin Microbiol (2009) 2.58
Clinical experience with linezolid for the treatment of nocardia infection. Clin Infect Dis (2003) 2.37
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2006) 2.34
Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis (2003) 2.19
Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey. J Clin Microbiol (2011) 2.13
Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev (2012) 2.11
Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol (2009) 2.03
Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol (2004) 2.00
Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother (2002) 1.89
Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol (2005) 1.83
Occurrence of mycobacteria in water treatment lines and in water distribution systems. Appl Environ Microbiol (2002) 1.78
Use of the MGB Eclipse system and SmartCycler PCR for differentiation of Mycobacterium chelonae and M. abscessus. J Clin Microbiol (2005) 1.75
Predominance of ancestral lineages of Mycobacterium tuberculosis in India. Emerg Infect Dis (2006) 1.75
Mycobacterium pseudoshottsii sp. nov., a slowly growing chromogenic species isolated from Chesapeake Bay striped bass (Morone saxatilis). Int J Syst Evol Microbiol (2005) 1.72
Sequence-based identification of aerobic actinomycetes. J Clin Microbiol (2004) 1.70
Accidental exposures to blood and body fluid in the operation room and the issue of underreporting. Am J Infect Control (2009) 1.66
Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov. J Clin Microbiol (2004) 1.61
Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med (2012) 1.59
Clinical and laboratory features of Mycobacterium mageritense. J Clin Microbiol (2002) 1.58
Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. Int J Syst Evol Microbiol (2004) 1.51
Chlorine disinfection of atypical mycobacteria isolated from a water distribution system. Appl Environ Microbiol (2002) 1.50
Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest (2005) 1.49
Trombone player's lung: a probable new cause of hypersensitivity pneumonitis. Chest (2010) 1.48
Multicenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2004) 1.44
An outbreak of Mycobacterium chelonae infection following liposuction. Clin Infect Dis (2002) 1.44
Newly described or emerging human species of nontuberculous mycobacteria. Infect Dis Clin North Am (2002) 1.43
Intrinsic macrolide resistance in rapidly growing mycobacteria. Antimicrob Agents Chemother (2006) 1.37
Pulsed-field gel electrophoresis study of Mycobacterium abscessus isolates previously affected by DNA degradation. J Clin Microbiol (2004) 1.37
Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother (2004) 1.35
First isolations of Segniliparus rugosus from patients with cystic fibrosis. J Clin Microbiol (2007) 1.33
Presence of a single genotype of the newly described species Mycobacterium immunogenum in industrial metalworking fluids associated with hypersensitivity pneumonitis. Appl Environ Microbiol (2002) 1.29
Forty years of disinfectant failure: outbreak of postinjection Mycobacterium abscessus infection caused by contamination of benzalkonium chloride. Clin Infect Dis (2003) 1.28
Nocardia wallacei sp. nov. and Nocardia blacklockiae sp. nov., human pathogens and members of the "Nocardia transvalensis Complex". J Clin Microbiol (2008) 1.26
Mycobacterium simae outbreak associated with a hospital water supply. Infect Control Hosp Epidemiol (2004) 1.21
High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks. Emerg Infect Dis (2014) 1.21
Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis. J Infect Dis (2002) 1.21
Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease. J Clin Microbiol (2013) 1.20
Diagnosed tuberculosis during the follow-up of a cohort of human immunodeficiency virus-infected children in Abidjan, Côte d'Ivoire: ANRS 1278 study. Pediatr Infect Dis J (2005) 1.18
Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, Northeastern USA. Emerg Infect Dis (2011) 1.16
A novel apoptosis-inducing protein from Helicobacter pylori. Mol Microbiol (2003) 1.14
Use of the INNO-LiPA-MYCOBACTERIA assay (version 2) for identification of Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complex isolates. J Clin Microbiol (2005) 1.14
Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species. J Clin Microbiol (2012) 1.12
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother (2003) 1.12
Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2005) 1.12
A long-term study of sharps injuries among health care workers in Japan. Am J Infect Control (2007) 1.11
Mycobacterium africanum genotyping using novel spacer oligonucleotides in the direct repeat locus. J Clin Microbiol (2004) 1.10
An unusual presentation of primary hyperparathyroidism: severe hypercalcemia and multiple brown tumors. Joint Bone Spine (2007) 1.09
Clinical and laboratory features of Mycobacterium porcinum. J Clin Microbiol (2004) 1.08
Is Mycobacterium africanum subtype II (Uganda I and Uganda II) a genetically well-defined subspecies of the Mycobacterium tuberculosis complex? J Clin Microbiol (2003) 1.08
In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates. J Clin Microbiol (2013) 1.06
In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria. Antimicrob Agents Chemother (2003) 1.05
Phylogenetic analysis of Mycobacterium aurum and Mycobacterium neoaurum with redescription of M. aurum culture collection strains. Int J Syst Evol Microbiol (2009) 1.05
Extrasynovial ultrasound abnormalities in the psoriatic finger. Prospective comparative power-doppler study versus rheumatoid arthritis. Joint Bone Spine (2006) 1.05
Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas. Clin Infect Dis (2002) 1.04
Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease. Chest (2015) 1.04
Mycobacterium abscessus. "Pleased to meet you, hope you guess my name...". Ann Am Thorac Soc (2015) 1.02
Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria. Antimicrob Agents Chemother (2002) 1.01
Cloning and characterization of two novel DNases from Streptococcus pyogenes. Arch Microbiol (2002) 1.01
Mycobacterium sherrisii: a new opportunistic agent in HIV infection? AIDS (2007) 1.01